Atlas Trials

Combination Chemotherapy and Filgrastim Before Surgery in Treating Patients With HER2-Positive Breast Cancer That Can Be Removed By Surgery

Clinical trial NCT00194779 · COMPLETED

Trial details

NCT number
NCT00194779
Sponsor
University of Washington
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Estrogen Receptor-negative Breast CancerEstrogen Receptor-positive Breast CancerHER2-positive Breast CancerProgesterone Receptor-negative Breast CancerProgesterone Receptor-positive Breast CancerStage IA Breast CancerStage IB Breast CancerStage II Breast CancerStage IIIA Breast Cancer
Start date
2003-10-01
Primary completion
2010-06-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.